U.S. Purchases Stock Piles of H5N1 Vaccine
The vaccine was obtained from the human strain of H5N1 virus and is designed for people 18 to 64 that would be a greater risk of exposer. It would given as two intramuscular shots given a month apart. The study showedThe vaccine is manufactured by, Sanofi Pasteur Inc., and will not be available for commercial distribution. It will be purchased by the United states for inclusion into the U.S. Strategic National Stockpile for distribution in the case of an outbreak here in the U.S. It will be made in the Sanofi Pasteur's Swiftwater, PA's facility. The vaccine will be available within twelve hours to any state in the event of an out break.
For more information on the Avian Flu Vaccine go the the FDA's Website at, http://www.fda.gov/bbs/topics/NEWS/2007/NEW01611.html
(http://www.fda.gov/bbs/topics/NEWS/2007/NEW01611.html)
Protein Change Could Make Bird Flu Deadlier
Researchers at the University of Wisconsin-Madison have identified a key protein change that could make it easier for the bird flu virus to infect by person-to-person.
Is Human to Human Transmission of Avian Bird Flu Possible?
What binds the success men have still against the reach of a pandemic is that H5N1 spreads only from a bird to a human. The need of the hour is take a quicker look to examine the nature of such a belief.
Real Facts About the Bird Flu
As the media and government officials continue to spread fear about the avian flu, or bird flu as it is commonly known, it is important to take a logical look at this disease.
Bird Flu: The Next Pandemic?
This article look into the causes and consequences of an impending flu pandemic, The bird flu.
|
|
Type in Your Comments Below